Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 46 AL 60

Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions

Ma C, Hong F, Yang S.

Molecules. 2022 Feb 11;27(4):1210. doi: 10.3390/molecules27041210.

Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers

Álvarez-Sánchez L, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

J Alzheimers Dis. 2022;86(3):1337-1369. doi: 10.3233/JAD-215093.

Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature

Zetterberg H.

Alzheimers Dement. 2022 Sep;18(9):1687-1693. doi: 10.1002/alz.12618. Epub 2022 Feb 25.

Exosomal MicroRNA-Based Predictive Model for Preclinical Alzheimer's Disease: A Multicenter Study

Jia L, Zhu M, Yang J, Pang Y, Wang Q, Li T, Li F, Wang Q, Li Y, Wei Y.

Biol Psychiatry. 2022 Jul 1;92(1):44-53. doi: 10.1016/j.biopsych.2021.12.015. Epub 2022 Jan 3.

Increased Brain Volume: A Novel Biomarker of Neurodegeneration?

DiFrancesco JC, Stanzani L.

Neurology. 2022 Apr 19;98(16):649-650. doi: 10.1212/WNL.0000000000200166. Epub 2022 Feb 28.

Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease:a systematic review with meta-analysis

Cheng L, Li W, Chen Y, Lin Y, Wang B, Guo Q, Miao Y.

J Neurol Neurosurg Psychiatry. 2022 May;93(5):513-520. doi: 10.1136/jnnp-2021-327864. Epub 2022 Mar 3.

Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease

Cid REC, Loewenstein DA.

Neurotherapeutics. 2022 Jan;19(1):89-98. doi: 10.1007/s13311-022-01192-0. Epub 2022 Mar 4.

Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease

Shi Y, Bao Q, Chen W, Wang L, Peng D, Liu J, Liu Q, Zhang Y, Ji Z, Shen A.

J Alzheimers Dis. 2022;87(1):1-15. doi: 10.3233/JAD-215666.

Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis

Yoon S, Kim SE, Ko Y, Jeong GH, Lee KH, Lee J, Solmi M, Jacob L, Smith L, Stickley A, Carvalho AF, Dragioti E, Kronbichler A, Koyanagi A, Hong SH, Thompson T, Oh H, Salazar de Pablo G, Radua J, Shin JI, Fusar-Poli P.

Mol Psychiatry. 2022 May;27(5):2405-2413. doi: 10.1038/s41380-022-01476-z. Epub 2022 Mar 9.

Advances in aptamers against Aβ and applications in Aβ detection and regulation for Alzheimer's disease

Zheng Y, Zhang L, Zhao J, Li L, Wang M, Gao P, Wang Q, Zhang X, Wang W.

Theranostics. 2022 Jan 31;12(5):2095-2114. doi: 10.7150/thno.69465. eCollection 2022.

Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration

Romaus-Sanjurjo D, Regueiro U, López-López M, Vázquez-Vázquez L, Ouro A, Lema I, Sobrino T.

Int J Mol Sci. 2022 Feb 24;23(5):2486. doi: 10.3390/ijms23052486.

A systematic survey of advances in retinal imaging modalities for Alzheimer's disease diagnosis

Vij R, Arora S.

Metab Brain Dis. 2022 Oct;37(7):2213-2243. doi: 10.1007/s11011-022-00927-4. Epub 2022 Mar 15.

New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease

David M, Malhotra PA.

Ann Clin Transl Neurol. 2022 Apr;9(4):582-596. doi: 10.1002/acn3.51539. Epub 2022 Mar 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias